Inventiva Seeks Shareholder Approval for Extensive Capital Raises & Refinancing Measures

summarizeSummary

Inventiva S.A. has mailed its proxy card for a June 30, 2026, shareholder meeting, seeking approval for numerous proposals including significant capital increases, an At-The-Market program, and a resolution regarding its shareholders' equity being below half its share capital.

check_boxKey Events · Financing and Capital Events · IVA

• Shareholder Meeting Scheduled

  Inventiva will hold an Ordinary and Extraordinary General Meeting on June 30, 2026, to vote on 40 proposals, including critical financial and governance matters.

• Extensive Capital Increase Authorizations

  Shareholders will vote on multiple delegations of authority to the Board to increase share capital through various means, including public offerings, private placements, and an At-The-Market (ATM) program, enabling significant future dilution.

• Resolution for Equity Deficit

  A critical proposal addresses the company's shareholders' equity falling below half its share capital, a mandatory resolution under French commercial law following previous disclosures of financial distress.

• European Investment Bank Warrants

  Shareholders will vote on the issuance of share subscription warrants to the European Investment Bank, a component of the company's refinancing efforts.

auto_awesomeAnalysis · IVA · Life Sciences

This proxy filing details the critical shareholder votes required to implement Inventiva's previously announced refinancing package and address its severe financial distress, including a "going concern" warning. The proposals authorize the Board to issue substantial new equity, including through an At-The-Market (ATM) program and warrants to the European Investment Bank, which will be highly dilutive but are essential for the company's continued operations. Shareholders will also vote on a resolution concerning the company's equity falling below half its share capital, a mandatory step under French law.